Revenue, last quarter
$35.5M
+30.3% vs same quarter last year
Net income
−$24.4M
−71.4% vs same quarter last year
EPS, diluted
−$0.52
−57.6% vs same quarter last year
Operating cash flow
−$12.3M
−40.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $100.3M | −$73.2M |
| FY24 | $65.1M | −$54.8M |
| FY23 | $12M | −$44.1M |
| FY22 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 55.4% | −71.5% | −73% |
| FY24 | 55.1% | −69.5% | −84.1% |
| FY23 | 52.6% | −298.9% | −367.6% |
| FY22 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$56.2M |
| FY24 | −$51.7M |
| FY23 | −$32.8M |
| FY22 | - |
- Beta Bionics
- Healthcare median
Show the numbers
| Year | Beta Bionics | Healthcare median |
|---|---|---|
| FY25 | −73% | −30.6% |
| FY24 | −84.1% | −47% |
| FY23 | −367.6% | −58% |
| FY22 | - | −80.4% |